Striking the Balance: Patient Care, Activism, and Public Service in the Health Professions    

Gail E. Henderson, PhD, is professor of Social Medicine in the School of Medicine, and Director of the UNC Center for Genomics and Society. She was Chair of Social Medicine from 2009 to 2015, and co-Director of the Center for AIDS Research International Core from 2004 to 2014.  Her teaching and research interests include global … Read more

Dr. Karen Meagher graduated in Hamilton College in 2004 with a B.A.in biology. She received a PhD in Philosophy from Michigan State University in 2012, her dissertation was entitled A Virtue Approach to Public Health Ethics. While at Michigan State, she served as an undergraduate advisor in the Center for Ethics and Humanities in the … Read more

Dr. Resnik has an M.A. and Ph.D. in philosophy from the University of North Carolina at Chapel Hill and J.D. from Concord University School of Law. He received his B.A. in philosophy from Davidson College. Dr. Resnik was an Associate and Full Professor of Medical Humanities at the Brody School of Medicine at East Carolina … Read more

This event is co-sponsored by the Parr Center for Ethics and the UNC Center for Bioethics. For more information, see the Parr Center Events: CRISPR: The History, Science and Ethics of Genetic Modification.

Can research subjects be “wronged” even if not physically injured in a clinical trial? Thorny questions of how to account for such intangible harm currently challenge the courts, regulatory agencies, and IRBs. This presentation will consider the legal, ethical, and policy implications of noteworthy cases involving intangible harm, including alleged breach of dignitary rights, abrupt … Read more

Compensating research participants has been the subject of national debate for some time. In this presentation, I will review the four most common approaches to paying research participants and critically evaluate the impact of these schemes with relation to the risk:benefit ratio in research. I will also present the growing empirical literature on the varying … Read more

The 2014 Ebola epidemic in west Africa is the most severe and largest documented to date. It is also the first epidemic in which the use of experimental vaccines and specific treatments for Ebola was endorsed at an early stage. This talk will draw lessons from Ebola for conducting clinical research during an epidemic, with … Read more

Biobanking is becoming an increasingly important component of genomic and medical research. President Obama’s Precision Medicine Initiative ― which proposes the collection of genetic and clinical data for upwards of 1 million Americans ― is just one example of this trend in medical science.  Because biobanks depend upon donations from a willing public, it is important that potential … Read more

Clinical trial recruitment is in crisis. The public typically encounters clinical trial information in controversies or study-specific recruitment ads, which limits full understanding. To help address the national clinical trial recruitment crisis, researchers at UNC-CH used the social marketing approach to develop an evidence-based, online clinical research website and registry called Join the Conquest. This … Read more